临床肺科杂志
臨床肺科雜誌
림상폐과잡지
JOUNAL OF CLINICAL PULMONARY MEDICINE
2014年
12期
2192-2194
,共3页
韦俊平%杨瑞青%刘斌%郑发德
韋俊平%楊瑞青%劉斌%鄭髮德
위준평%양서청%류빈%정발덕
降钙素原%超敏C反应蛋白%AECOPD
降鈣素原%超敏C反應蛋白%AECOPD
강개소원%초민C반응단백%AECOPD
calcitonin original%hypersensitive C-reactive protein%AECOPD
目的:探讨降钙素原( PCT )与超敏 C反应蛋白( hs-CRP )在慢性阻塞性肺疾病急性加重期( AECOPD)临床意义及相关性研究。方法选择78例AECOPD及34例慢性阻塞性肺疾病( COPD)稳定期患者,分别测定治疗前后及稳定期患者的血清PCT、hs-CRP的浓度。结果急性期患者治疗前血清PCT、hs-CRP的浓度明显高于治疗后及稳定期患者,其阳性率较高,分别80.8%、75.6%,其治疗前后的水平变化同治疗后患者病情变化有明显的相关性。结论 PCT及hs-CRP是诊断AECOPD的较好指标,联合检测两者对AECOPD的治疗及效果评价有重要的临床意义。
目的:探討降鈣素原( PCT )與超敏 C反應蛋白( hs-CRP )在慢性阻塞性肺疾病急性加重期( AECOPD)臨床意義及相關性研究。方法選擇78例AECOPD及34例慢性阻塞性肺疾病( COPD)穩定期患者,分彆測定治療前後及穩定期患者的血清PCT、hs-CRP的濃度。結果急性期患者治療前血清PCT、hs-CRP的濃度明顯高于治療後及穩定期患者,其暘性率較高,分彆80.8%、75.6%,其治療前後的水平變化同治療後患者病情變化有明顯的相關性。結論 PCT及hs-CRP是診斷AECOPD的較好指標,聯閤檢測兩者對AECOPD的治療及效果評價有重要的臨床意義。
목적:탐토강개소원( PCT )여초민 C반응단백( hs-CRP )재만성조새성폐질병급성가중기( AECOPD)림상의의급상관성연구。방법선택78례AECOPD급34례만성조새성폐질병( COPD)은정기환자,분별측정치료전후급은정기환자적혈청PCT、hs-CRP적농도。결과급성기환자치료전혈청PCT、hs-CRP적농도명현고우치료후급은정기환자,기양성솔교고,분별80.8%、75.6%,기치료전후적수평변화동치료후환자병정변화유명현적상관성。결론 PCT급hs-CRP시진단AECOPD적교호지표,연합검측량자대AECOPD적치료급효과평개유중요적림상의의。
Objective To investigate the clinical application value and its correlation of serum procalcitonin (PCT) and high-sensitivity C-reactive protiein (hs-CRP) in AECOPD patients. Methods The study selected 78 patients with AECOPD as the study group and 34 COPD patients at stable period as the control group. The levels of PCT and hs-CRP were detected in all patients before and after the treatment. Results Before the treatment, the ser-um levels of PCT and hs-CRP were significantly higher in the study group than in the control group, and it decreased significantly after the treatment. The positive rate was 80. 8% and 75. 6% respectively. The changes of PCT and hs-CRP before and after the treatment had obvious correlation with the changes of disease in COPD patients. Conclusion PCT and hs-CRP are good indexes for the diagnosis of AECOPD, and the joint detection has important clinical sig-nificance for the treatment and evaluation of AECOPD patients.